Keywords: Bayer, Janssen, Portola, Xarelto, Antidote, Johnson & Johnson, PRT4445, Factor Xa inhibitors

Bayer and Janssen link with Portola for Xarelto antidote

Article | 06 February 2013

Print This

Germany’s Bayer (BAYN: DE) and Janssen Pharmaceuticals, a part of US health care giant Johnson & Johnson (NYSE: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in